S100A9 and myeloproliferative disorder: The absence of S100a9 in HSPCs in TPO induced MF led to a reduction of WBC and platelet counts compared to HSPCs expression normal S100a9 levels, indicating an improvement of the MPN phenotype (Figure 4D).